This is the authors' abstract. We don't add key points for this paper.
Ifosfamide is a widely used chemotherapeutic agent for the treatment of a broad spectrum of solid tumors. CNS toxicity is a well-described side effect of ifosfamide, but the mechanism of ifosfamide-induced neurotoxicity remains poorly defined. We present two pediatric cases of hemiballismic limb movements in the setting of ifosfamide-associated encephalopathy. To our knowledge, there have been no prior reports of ifosfamide-induced hemiballism in pediatric patients. One of our patient's encephalopathy and abnormal movements may have improved after the administration of methylene blue and thiamine.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Ames et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: